1988 Hand Caste of Charles Aznouvior who had diabetes, and laid as part of
a celebrity pavement feature in Cannes France Picture Julian Bray
Over 347 million people worldwide living with diabetes were recorded in 2008,and it continues to grow at an alarming rate, according to the World Health Organisation.
The disease caused some 1.5 million deaths in 2012 and expected to be the world’s seventh largest killer unless people take preventative action or seek treatment, taking responsibility for the management of their condition.
In the UK alone over 3.2 million have been diagnosed with diabetes - an increase of 163,000 since 2012.
Clinical research is a vital weapon in the war against conditions such as diabetes; treatments used to manage illnesses and diseases today are the result of decades of ongoing research to enable patients to live longer and fuller lives.
Diabetes is the focus of World Health Day, an annual event organised by the World Health Organisation and taking place this year on April 7th.
The WHO has selected diabetes as the main focus because of the rapid increase in many countries across the world and because Type 2 of the disease – which accounts for 90 per cent of the cases worldwide - is largely preventable by making simple lifestyle changes. Once diagnosed, patients are able to control and manage the condition to prevent associated complications such as heart attacks, strokes, nerve damage, kidney failure, blindness, impotence and infections that can result in amputations.
The WHO said increased access to diagnosis, self-management education and affordable treatment are also regarded as vital to the long-term fight against the condition, with governments, employers, educators, manufacturers, civil society, the private sector, media and individuals themselves all playing a crucial part.
London-based clinical research specialist MeDiNova has stepped up its fight against the disease and is currently undertaking three studies to test the effectiveness of new treatments for Type 2 diabetes.
The attention being given to the disease clearly demonstrates the importance which is being attributed to finding more effective treatment measures as the battle goes on to get to grips with this ever growing disease.
MeDiNova operates clinics in Northwood, north London, Sidcup, south London and Romford in east London and is now seeking volunteers to take part in the trials.
For further details about clinical research and forthcoming studies log on to www.improvingtreatments.co.uk or email firstname.lastname@example.org
E&OE google.com/+JulianBray Tel:+44 (0) 1733 345581 .